Table 4.
Isoflavone intake levels in groups of ulcerative colitis individuals declaring lack of constipations and declaring presence of constipations (comparison conducted using U Mann-Whitney test)
|
Individuals declaring lack of constipations
(n = 49) |
Individuals declaring constipations
(n = 7) |
P value | |||
| Mean ± SD | Median (min-max) | Mean ± SD | Median (min-max) | ||
| Intake | |||||
| Daidzein (μg) | 147.0 ± 158.0 | 117.71 (3.3-977.7) | 127.0 ± 128.6 | 73.0 (11.3-353.0) | 0.6827 |
| Genistein (μg) | 183.6 ± 219.9 | 137.01 (2.3-1428.3) | 134.9 ± 208.8 | 67.01 (6.7-586.7) | 0.1891 |
| Glycitein (μg) | 1.0 ± 5.1 | 0.01 (0.0-33.3) | 8.6 ± 21.0 | 0.01 (0.0-56.0) | 0.0213 |
| Total isoflavones (μg) | 331.6 ± 282.8 | 262.71 (27.7-1574.0) | 270.5 ± 300.4 | 123.7 (18.0-833.0) | 0.3339 |
| Intake per 1000 kcal | |||||
| Daidzein (μg/1000 kcal) | 146.8 ± 161.0 | 117.71 (3.3-977.7) | 101.1 ± 124.2 | 46.2 (5.4-347.7) | 0.9802 |
| Genistein (μg/1000 kcal) | 183.3 ± 224.2 | 137.01 (2.3-1428.3) | 97.6 ± 152.0 | 37.11 (3.2-426.6) | 0.4279 |
| Glycitein (μg/1000 kcal) | 1.0 ± 5.2 | 0.01 (0.0-33.3) | 5.7 ± 6.7 | 0.01 (0.0-37.4) | 0.0213 |
| Total isoflavones (μg/1000 kcal) | 331.1 ± 287.9 | 262.71 (27.7-1574.0) | 204.5 ± 236.1 | 68.4 (8.6-605.7) | 0.7102 |
1
Nonparametric distribution (verified using the Shapiro-Wilk test; P < 0.05).